Bailard’s Acceleron Pharma XLRN Stock Holding History

Bailard’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$344K	–	812
2021 Q3	$344K	Hold	2,000	–	–	0.01%	490
2021 Q2	$251K	Sell	2,000 -900	-31%	-$114K	0.01%	607
2021 Q1	$393K	Hold	2,900	–	–	0.01%	444
2020 Q4	$371K	Sell	2,900 -3,100	-52%	-$363K	0.02%	393
2020 Q3	$675K	Sell	6,000 -1,000	-14%	-$99.6K	0.04%	245
2020 Q2	$667K	Hold	7,000	–	–	0.04%	232
2020 Q1	$629K	Sell	7,000 -1,000	-13%	-$77.7K	0.04%	205
2019 Q4	$424K	Sell	8,000 -5,000	-38%	-$228K	0.02%	333
2019 Q3	$514K	Hold	13,000	–	–	0.03%	264
2019 Q2	$534K	Buy	13,000 +2,600	+25%	+$108K	0.03%	274
2019 Q1	$484K	Hold	10,400	–	–	0.03%	302
2018 Q4	$453K	Sell	10,400 -2,800	-21%	-$140K	0.03%	321
2018 Q3	$755K	Sell	13,200 -300	-2%	-$14.7K	0.04%	248
2018 Q2	$655K	Buy	13,500 +3,000	+29%	+$109K	0.04%	284
2018 Q1	$411K	Buy	10,500 +2,500	+31%	+$106K	0.03%	371
2017 Q4	$340K	Buy	+8,000	New	+$300K	0.02%	358

Bailard's XLRN Position: Q4 2021 in Review

Bailard sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,000 shares — an estimated $344K sold.

Bailard first reported a position in XLRN in Q4 2017 and held it in 16 quarters. The position peaked at $755K in Q3 2018. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Bailard reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Bailard sold 2,000 Acceleron Pharma shares in Q4 2021, an estimated $344K.
Bailard first reported a position in Acceleron Pharma in Q4 2017 and held it in 16 quarters.
Bailard's Acceleron Pharma position peaked at $755K in Q3 2018.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bailard's 13F filing for Q4 2021, filed 10 Feb 2022.